Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nursing Homes | 13 | 2024 | 661 | 2.300 |
Why?
|
| Delivery of Health Care | 3 | 2023 | 411 | 1.660 |
Why?
|
| Quality Improvement | 8 | 2024 | 417 | 1.600 |
Why?
|
| United States Department of Veterans Affairs | 5 | 2023 | 519 | 1.480 |
Why?
|
| Quality of Health Care | 8 | 2023 | 513 | 1.310 |
Why?
|
| Veterans | 4 | 2024 | 728 | 1.200 |
Why?
|
| Geriatrics | 1 | 2023 | 41 | 0.850 |
Why?
|
| Community-Based Participatory Research | 1 | 2023 | 45 | 0.810 |
Why?
|
| Health Services | 2 | 2021 | 81 | 0.810 |
Why?
|
| Patients | 1 | 2023 | 103 | 0.800 |
Why?
|
| Telemedicine | 2 | 2023 | 307 | 0.750 |
Why?
|
| Long-Term Care | 3 | 2023 | 176 | 0.700 |
Why?
|
| Evidence-Based Practice | 1 | 2019 | 79 | 0.610 |
Why?
|
| Physicians | 1 | 2023 | 440 | 0.600 |
Why?
|
| Homes for the Aged | 2 | 2018 | 157 | 0.590 |
Why?
|
| Qualitative Research | 5 | 2023 | 619 | 0.580 |
Why?
|
| Drug Utilization | 2 | 2016 | 208 | 0.550 |
Why?
|
| Oxycodone | 1 | 2016 | 30 | 0.520 |
Why?
|
| Morphine | 1 | 2016 | 51 | 0.520 |
Why?
|
| Fentanyl | 1 | 2016 | 72 | 0.500 |
Why?
|
| United States | 10 | 2023 | 7426 | 0.490 |
Why?
|
| Marketing of Health Services | 1 | 2015 | 23 | 0.470 |
Why?
|
| Chronic Pain | 1 | 2016 | 134 | 0.450 |
Why?
|
| Medicare Part D | 1 | 2013 | 37 | 0.430 |
Why?
|
| Humans | 26 | 2024 | 59366 | 0.430 |
Why?
|
| Pain Management | 1 | 2015 | 146 | 0.420 |
Why?
|
| Neoplasms | 4 | 2016 | 1231 | 0.400 |
Why?
|
| Antipsychotic Agents | 1 | 2015 | 292 | 0.390 |
Why?
|
| Motivation | 4 | 2023 | 274 | 0.390 |
Why?
|
| Rural Population | 2 | 2023 | 188 | 0.370 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 483 | 0.370 |
Why?
|
| Evidence-Based Medicine | 1 | 2013 | 442 | 0.360 |
Why?
|
| Aged | 8 | 2023 | 13405 | 0.340 |
Why?
|
| Cross-Sectional Studies | 4 | 2022 | 2380 | 0.280 |
Why?
|
| Communication | 2 | 2021 | 545 | 0.250 |
Why?
|
| Quality of Life | 3 | 2024 | 1137 | 0.250 |
Why?
|
| Group Processes | 1 | 2023 | 41 | 0.220 |
Why?
|
| Work Engagement | 2 | 2020 | 14 | 0.220 |
Why?
|
| Patient Safety | 2 | 2023 | 237 | 0.210 |
Why?
|
| Ambulatory Care Facilities | 1 | 2023 | 101 | 0.210 |
Why?
|
| Delphi Technique | 1 | 2023 | 77 | 0.200 |
Why?
|
| Awareness | 1 | 2021 | 74 | 0.170 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2016 | 692 | 0.170 |
Why?
|
| Operating Rooms | 1 | 2020 | 55 | 0.170 |
Why?
|
| Mentoring | 1 | 2020 | 46 | 0.170 |
Why?
|
| Caregivers | 1 | 2022 | 231 | 0.160 |
Why?
|
| Dementia | 1 | 2023 | 248 | 0.160 |
Why?
|
| Mentors | 1 | 2020 | 116 | 0.160 |
Why?
|
| Health Services Accessibility | 1 | 2023 | 527 | 0.160 |
Why?
|
| Nursing Staff | 1 | 2019 | 39 | 0.150 |
Why?
|
| Gene-Environment Interaction | 2 | 2016 | 48 | 0.150 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 331 | 0.140 |
Why?
|
| Aged, 80 and over | 3 | 2016 | 5119 | 0.140 |
Why?
|
| Professional-Patient Relations | 1 | 2018 | 126 | 0.140 |
Why?
|
| Patient Care Team | 1 | 2020 | 327 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 192 | 0.140 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 205 | 0.140 |
Why?
|
| Organizational Innovation | 1 | 2017 | 81 | 0.140 |
Why?
|
| Oxymorphone | 1 | 2016 | 5 | 0.130 |
Why?
|
| Administration, Cutaneous | 1 | 2016 | 26 | 0.130 |
Why?
|
| Organizational Culture | 1 | 2017 | 106 | 0.130 |
Why?
|
| Tramadol | 1 | 2016 | 16 | 0.130 |
Why?
|
| Rhode Island | 1 | 2016 | 98 | 0.130 |
Why?
|
| Patient Participation | 1 | 2018 | 216 | 0.130 |
Why?
|
| Delayed-Action Preparations | 1 | 2016 | 111 | 0.130 |
Why?
|
| Sulfonylurea Compounds | 1 | 2015 | 13 | 0.120 |
Why?
|
| Pandemics | 1 | 2020 | 616 | 0.120 |
Why?
|
| Health Facility Size | 1 | 2015 | 16 | 0.120 |
Why?
|
| Environmental Exposure | 2 | 2016 | 209 | 0.120 |
Why?
|
| Connecticut | 1 | 2015 | 86 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 805 | 0.110 |
Why?
|
| Analgesics | 1 | 2015 | 96 | 0.110 |
Why?
|
| Cluster Analysis | 1 | 2015 | 245 | 0.110 |
Why?
|
| Fractures, Bone | 1 | 2015 | 136 | 0.110 |
Why?
|
| Accidental Falls | 1 | 2015 | 124 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 725 | 0.110 |
Why?
|
| Activities of Daily Living | 1 | 2015 | 289 | 0.100 |
Why?
|
| Buprenorphine | 1 | 2016 | 181 | 0.100 |
Why?
|
| Prescription Drugs | 1 | 2013 | 47 | 0.100 |
Why?
|
| Genes | 1 | 2013 | 90 | 0.100 |
Why?
|
| Research Support as Topic | 1 | 2013 | 39 | 0.100 |
Why?
|
| Aging | 1 | 2018 | 710 | 0.100 |
Why?
|
| Biomedical Research | 1 | 2013 | 256 | 0.080 |
Why?
|
| Male | 4 | 2018 | 27742 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 635 | 0.080 |
Why?
|
| Female | 4 | 2018 | 30719 | 0.070 |
Why?
|
| Skilled Nursing Facilities | 1 | 2023 | 83 | 0.050 |
Why?
|
| Palliative Care | 1 | 2022 | 214 | 0.040 |
Why?
|
| Perioperative Care | 1 | 2020 | 76 | 0.040 |
Why?
|
| Faculty, Medical | 1 | 2020 | 192 | 0.040 |
Why?
|
| Observation | 1 | 2018 | 29 | 0.040 |
Why?
|
| Organizational Case Studies | 1 | 2018 | 40 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2019 | 484 | 0.030 |
Why?
|
| Cooperative Behavior | 1 | 2018 | 210 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 2018 | 256 | 0.030 |
Why?
|
| Veterans Health | 1 | 2017 | 158 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2018 | 246 | 0.030 |
Why?
|
| Life Style | 1 | 2016 | 299 | 0.030 |
Why?
|
| Genome, Human | 1 | 2016 | 224 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2016 | 439 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2015 | 674 | 0.030 |
Why?
|
| Hypoglycemic Agents | 1 | 2015 | 192 | 0.030 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2013 | 33 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 1238 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1051 | 0.020 |
Why?
|
| Middle Aged | 2 | 2018 | 16310 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2015 | 6069 | 0.010 |
Why?
|